Search
for

    Sort by

    Research 30 of 453

    1. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    2. What are the possible reasons for urethral PSA varieties after radical prostatectomy? Acta Chirurgica Iugoslavica · 2010 · 5 citations
    3. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    4. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    5. S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY European Urology Supplements · 2010
    6. S2 PSA: RELIABLE OR NOT RELIABLE? European Urology Supplements · 2010
    7. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? Journal of Obstetrics and Gynaecology Research · 2007 · 16 citations
    8. Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping Clinical Chemistry · 2016 · 8 citations
    9. Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007
    10. Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss? Nature Clinical Practice Urology · 2007
    11. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    12. UP-02.010 Urinary PSA: Marker of Benign Prostatic Hyperplasia? Urology · 2011
    13. UP-02.011 Biofeedback Treatment for Dysfunctional Voiding Diagnosed in Adulthood Urology · 2011
    14. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    15. African Journal of Biomedical Research 2025
    16. Urological Oncology: Testis Cancer and Advances in Oncological Therapy The Journal of Urology · 2007
    17. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase Scientific Reports · 2016 · 43 citations
    18. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    19. Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats Research and reports in urology · 2022 · 6 citations
    20. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    21. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    22. Economic analysis of finasteride: A model-based approach using data from the Proscar long-term efficacy and safety study Clinical Therapeutics · 1999 · 23 citations
    23. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    24. Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus) Reproduction, Fertility and Development · 2018 · 3 citations
    25. 9 Role of 5α-reductase in health and disease Baillière's clinical endocrinology and metabolism · 1994 · 101 citations
    26. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    27. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    28. Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases The Journal of Steroid Biochemistry and Molecular Biology · 2013 · 51 citations
    29. Regulation of masculinization: androgen signalling for external genitalia development Nature Reviews Urology · 2018 · 45 citations
    30. The Effect of Finasteride on the Expression of Vascular Endothelial Growth Factor and Microvessel Density: A Possible Mechanism for Decreased Prostatic Bleeding in Treated Patients The Journal of Urology · 2003 · 90 citations